Mawadda Chukr: What 10 Randomized Trials Reveal About Novel ITP Therapies
Mawadda Chukr, Student at Aleppo University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cytokine, adding:
“My first publication is officially out in Q1
We looked at novel therapies (SYK, FcRn, and BTK inhibitors) for adult Immune Thrombocytopenia (ITP) through a systematic review and meta-analysis of 10 RCTs.
I am so grateful to my co-authors for this amazing collaboration.
Check out the graphic below for our key highlights, or read the full paper via the link!”
Title: Efficacy and safety of IgG-pathway inhibitors in adult immune thrombocytopenia: A systematic review and meta-analysis with subgroup analyses of FcRn and SYK inhibitors
Authors: Mousa Almasalma, Ahmed Hamdy Kandil, Mahmoud Hashem Al-Qadi, Mohamed Lotfy Maarouf, Sara Mohammad Altaamreh, Weaam A. Soliman, Ahmed S. Mohamed, Ahmed Boshta, Nereen A. Almosilhy, Bashar Zahir Alsalhen, Mawadda Chukr

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week